anmelden
SLI
2.302,20
PKT
+4,24
PKT
+0,18
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.07.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 30.06.21 | Roche Outperform | Bernstein Research | |
| 30.06.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.06.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.06.21 | Nestlé overweight | Morgan Stanley | |
| 29.06.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 29.06.21 | Nestlé buy | Goldman Sachs Group Inc. | |
| 28.06.21 | UBS Outperform | Credit Suisse Group | |
| 28.06.21 | Roche Hold | Deutsche Bank AG | |
| 25.06.21 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
| 25.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.06.21 | Novartis Hold | Kepler Cheuvreux | |
| 24.06.21 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.06.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.06.21 | Holcim buy | Goldman Sachs Group Inc. | |
| 18.06.21 | Nestlé overweight | Barclays Capital | |
| 17.06.21 | Roche Hold | Deutsche Bank AG | |
| 17.06.21 | Novartis buy | Deutsche Bank AG | |
| 17.06.21 | Givaudan Underperform | Bernstein Research | |
| 16.06.21 | UBS overweight | JP Morgan Chase & Co. | |
| 16.06.21 | UBS Neutral | JP Morgan Chase & Co. | |
| 15.06.21 | UBS buy | Kepler Cheuvreux | |
| 15.06.21 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.06.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.06.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 15.06.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.06.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.06.21 | Holcim overweight | Morgan Stanley | |
| 11.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.21 | Roche Equal-Weight | Morgan Stanley | |
| 09.06.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 09.06.21 | Swiss Re overweight | Barclays Capital | |
| 09.06.21 | Zurich Insurance overweight | Barclays Capital | |
| 09.06.21 | Roche Hold | Jefferies & Company Inc. | |
| 08.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.06.21 | Givaudan Underperform | Credit Suisse Group | |
| 07.06.21 | Novartis Neutral | Credit Suisse Group | |
| 07.06.21 | Roche Neutral | Credit Suisse Group | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. |
